The Drug Enforcement Administration placed the drug lorcaserin into Schedule IV of the Controlled Substances Act. The weight loss drug had been approved by the Food and Drug Administration in June 2012. Effective June 7, lorcaserin will be subject to new registration, labeling, recordkeeping, and import and export requirements, among other things.
The International Trade Commission is publishing notices in the May 7 Federal Register on the following AD/CV injury, Section 337 patent, and other trade proceedings (any notices that warrant a more detailed summary will appear in another ITT article):
The Commerce Department published notices in the May 7 Federal Register on the following AD/CV duty proceedings (any notices that announce changes to AD/CV duty rates, scope, affected firms, or effective dates will be detailed in another ITT article):
The Commerce Department issued the preliminary results of its antidumping duty administrative review on activated carbon from China (A-570-904). The agency preliminarily denied Jacobi Carbons' request for company specific-revocation, because the company has not been assigned three consecutive zero rates -- Commerce found dumping by the company in the final results of the previous administrative review. These preliminary results are not in effect. Commerce may modify them in the final results of this review and change the estimated AD cash deposit rate for these companies.
Hanukkah candles imported and sold by Rite-Lite all are covered by the antidumping duty order on petroleum wax candles from China (A-570-504), said the Commerce Department in an April 30 scope ruling.
On May 6 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The Food and Drug Administration issued an order debarring David Freeman for five years from providing services to any person that has an approved or pending drug product application, in connection with his 2010 conviction for introducing and delivering into commerce a misbranded drug. Along with his accomplice Ashley Brandon Foyle, Freeman imported omeprazole from Muhi Trading Corporation, and his company Omega Biotech had repackaged and sold the drug. Neither Freeman, Omega, or Muhi Trading were registered to manufacture, prepare, propagate, compound, or process drugs, FDA said. The agency already published an order debarring Foyle on May 1 (see 13043018).
On May 6, the Foreign Agricultural Service posted the following GAIN reports:
The International Trade Administration’s Advisory Committee on Supply Chain Competitiveness will meet June 4 at 10 a.m. ET in Washington, D.C. The committee will continue to discuss topics raised at previous meetings, such as trade and competitiveness; freight movement and policy; information technology and data requirements; regulatory issues; and finance and infrastructure, the ITA said. The final agenda for the meeting will be posted one week before the meeting (here). The meeting will be open to the public on a first-come, first-served basis, but space will be limited, the ITA said.
A listing of recent antidumping and countervailing duty messages from the International Trade Administration posted to CBP's website May 6, along with the case number(s) and CBP message number, is provided below. The messages are available by searching for the listed CBP message number at addcvd.cbp.gov. (CBP occasionally adds backdated messages without otherwise indicating which message was added. ITT will include a message date in parentheses in such cases.)